{'fraction_non_alphanumeric': 0.013806706114398421, 'fraction_numerical': 0.0, 'mean_word_length': 5.597402597402597, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cervista HPV assays for fine‐needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma

The objectives of this study were to evaluate the validity of Cervista human papillomavirus (HPV) assays in head and neck fine‐needle aspiration (FNA) specimens from patients with head and neck squamous carcinomas and to verify that the Cervista assay in FNA specimens is a valid option for determining HPV status in patients with oropharyngeal carcinomas.